🔎 Trials Near Me

Gara Jalqabaatti › Dukkana Dhiigaa › California › Los Angeles

Qorannoo klinikaalii Dukkana Dhiigaa Los Angeles, CA keessatti

Qorannoo 17 Dukkana Dhiigaa f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Namoota walitti qabaa jiraSadarkaa 3
  • UCLA - Hematology/Oncology - Administrative Office ( Site 0009), Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03486873

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Namoota walitti qabaa jiraSadarkaa 3
  • Quetzal Site 7, Los Angeles
Umuriin 18 hanga 71 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07504458

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Namoota walitti qabaa jiraSadarkaa 2
  • UCLA Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04996875

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Health - Bowyer Oncology Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06001788

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06823167

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT05887167

Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant

Namoota walitti qabaa jiraSadarkaa 1
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT05849207

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
  • START Los Angele, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07424833

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Namoota walitti qabaa jiraSadarkaa 2
  • UCLA Department of Medicine, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UCLA, Los Angeles
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

Namoota walitti qabaa jiraSadarkaa 3
  • University of California LA, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT06401356

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT03207854

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UCLA - Bowyer Oncology Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Wax-2025 · NCT05768269

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

Namoota walitti qabaa jiraSadarkaa 1/2
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2025 · NCT06119685

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Namoota walitti qabaa jiraSadarkaa 1
  • Children's Hospital Los Angeles, Los Angeles
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Mud-2024 · NCT05476770

Qorannoo Dukkana Dhiigaa magaalota biroo keessatti

Qorannoo biroo Los Angeles keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.